Legend

All times listed are Central Daylight Time. Program and Faculty are updated often – check back for the most up-to-date information. Click on session name to view session description and component talks.

Type here to filter the list

Monday, Oct 27th
4:00 PM - 5:00 PM Central Time
Cancer Immunotherapy and Its Toxicities, Today and Tomorrow
Moderator: Jeffrey Sparks, MD;MSc – Brigham and Women's Hospital
Moderator: Sophia C. Weinmann, MD, FACR – Duke University
Session Coordinator: Janet Pope, MD;FRCPC;MPH – University of Western Ontario
Session Coordinator: Brittany Adler, MD – Johns Hopkins University
CE: 1
Monday, Oct 27th
4:00 PM - 4:30 PM Central Time
Current Cancer Immunotherapy Landscape and the Future
Speaker: Aliyah Pabani, MD;MPH – Johns Hopkins
CE: 1
Monday, Oct 27th
4:30 PM - 5:00 PM Central Time
When Cancer Therapy Triggers Autoimmunity: The Rheumatologist’s Role in Immune Checkpoint Inhibitors Toxicity
Speaker: Elad Sharon, MD,MPH – Dana-Farber Cancer Institute
CE: 1
Tuesday, Oct 28th
8:30 AM - 9:30 AM Central Time
The Good, the Bad, and the Ugly: Understanding Mechanisms of Adverse Events After Immune Checkpoint Therapy
Moderator: Sophia C. Weinmann, MD, FACR – Duke University
Session Coordinator: Teresa Tarrant, MD – Duke University
CE: 1
Tuesday, Oct 28th
8:30 AM - 8:50 AM Central Time
Pathogenesis of Immune checkpoint inhibitors-induced myocarditis
Speaker: Daniela Cihakova, PhD – Johns Hopkins University
CE: 1
Tuesday, Oct 28th
8:50 AM - 9:10 AM Central Time
Molecular and Immune Hallmarks of Immune-Related Adverse Event Inflammatory Arthritis Induced by Checkpoint Inhibitors
Speaker: Roza Nurieva, PhD – University of Texas MD Anderson
CE: 1
Tuesday, Oct 28th
9:10 AM - 9:30 AM Central Time
Mouse Model of Immune-Related Adverse Events
Speaker: Abby Overacre, PhD – University of Pittsburgh
CE: 1